Education and Mentorship of Advanced Practice Providers to Increase Community-based Research within the NCORP Network, COACH-APP Trial

Georgia's Online Cancer Information Center

Find A Clinical Trial

Education and Mentorship of Advanced Practice Providers to Increase Community-based Research within the NCORP Network, COACH-APP Trial

Status
Active
Cancer Type
Solid Tumor
Trial Phase
Eligibility
18 Years and older, Male and Female
Study Type
Health services research
NCT ID
NCT06904391
Protocol IDs
WF-2403 (primary)
WF-2403
WF-2403
NCI-2025-01059
Study Sponsor
Wake Forest NCORP Research Base

Summary

This clinical trial evaluates whether a mentorship and education intervention called COACH-APP works to improve advanced practice providers' (APPs) confidence in their ability to participate in clinical research (research self-efficacy). APPs are skilled clinicians who are routinely part of cancer care teams, but who may not routinely be part of the research care team at community oncology sites. The COACH-APP program provides focused education and structured mentorship to assist in meaningful integration to the research care team, which may increase research self-efficacy among APPs and ultimately improve patient care and access to clinical trials.

Objectives

PRIMARY OBJECTIVE:
I. To compare change in research self-efficacy (RSE) scores from baseline to end of study (12 months post-randomization) between APPs in the COACH-APP intervention compared to the education control.

SECONDARY OBJECTIVES:
I. To compare National Cancer Institute Community Oncology Research Program (NCORP) engagement post-study (12-months) for APPs in the COACH-APP intervention compared to the education control.
II. To compare changes from baseline to post-study in APP ratings of research care team integration (Assessment for Collaborative Environments [ACE]-15) between the COACH-APP intervention and education control.
III. To compare practice-level NCORP and National Clinical Trial Network (NCTN) study activity as measured by total number of accruals (patient, non-patient, and organizational) and number of actively recruiting NCORP and NCTN studies over 24 months between practices with APPs receiving the COACH-APP intervention versus those in education control.
IV. Within the COACH-APP intervention group, to measure acceptability, feasibility, and appropriateness of the COACH-APP intervention for APPs and COACH-APP mentors to guide future implementation.
V. Within the COACH-APP intervention group, conduct semi-structured interviews with a sub-set of mentors, APPs, and other key research team members (collaborating oncologists and clinical research professionals) to assess:
Va. Perceptions of feasibility, acceptability, and appropriateness of the COACH-APP intervention;
Vb. Potential effects of the COACH-APP intervention on the research care team functioning and environment;
Vc. Potential effects of the COACH-APP intervention on patient care quality and access to clinical trials;
Vd. Practice-level barriers and facilitators of APP engagement in research activities.

EXPLORATORY OBJECTIVES:
I. To compare additional practice-level NCORP and NCTN study activity (number of treating investigators and number of credit investigators over 12 and 24 months and total number of accruals and number of actively recruiting NCORP and NCTN studies over 12 months) between practices with APPs receiving the COACH-APP intervention versus those in education control.
II. To compare practice-level NCORP cancer control (CC) and cancer care delivery research (CCDR) study activity (number of actively recruiting NCORP studies, total number of accruals, number of treating investigators, and number of credit investigators) over 12 and 24 months between practices with APPs receiving the COACH-APP intervention versus those in education control.
III. To compare changes in NCORP CC and CCDR study accrual patient demographics (race, ethnicity, sex, residence in a medically underserved area) over 12 and 24 months between practices with APPs receiving the COACH-APP intervention versus those in education control.

OUTLINE: APPs are randomized to 1 of 2 arms.

ARM I: APPs complete the Southwest Oncology Group (SWOG) APP Clinical Research Workshop, consisting of 6 modules, over 2 hours and receive The Advanced Practice Provider Clinical Trials Research Manual. APPs also complete 5 mentoring sessions, over 15-60 minutes each, over 12 months.

ARM II: APPs receive access to the SWOG APP Clinical Research Workshop and The Advanced Practice Provider Clinical Trials Research Manual for 12 months.

After completion of study intervention, participants are followed up at 24 months.

Eligibility

  1. APP PRACTICE: Must have one practicing APP who can dedicate approximately 2 hours/month to participate in the intervention and study activities over a 12-month period, supported by their direct supervisor via the APP Support Statement
  2. APP PRACTICE: Must attest to research infrastructure that can support APP trial enrollment, as declared on the APP Practice Attestation
  3. APP PRACTICE: Must have submitted the APP Practice Attestation within the Study Interest Survey
  4. APP PRACTICE: Must have received the required APP practice ID for Oncology Patient Enrollment Network (OPEN) enrollment in the Study Selection Email prior to enrollment
  5. APP PRACTICE: Must enroll eligible practice site(s) in OPEN within 14 days of receiving the Study Selection Email
  6. APP: Practicing nurse practitioner (NP) or physician assistant (PA) registered as an active non-physician investigators (NPIVR) within the National Cancer Institute (NCI) Registration and Credential Repository (RCR)
  7. APP: Treats oncology patients at practice that is actively recruiting to NCORP and/or NCTN trials
  8. APP: Not planning to leave their clinical position within the APP practice (defined as one or more NCORP affiliate or sub-affiliate site[s] where the APP participating in the study sees patients and clinical research activities occur) in the next 12 months at enrollment
  9. APP: Willing to participate in a 30-minute recorded phone interview, if selected
  10. APP: Completed and submitted the APP Attestation within the Study Interest Survey
  11. APP: Completed and submitted an APP Support Statement from their direct supervisor approving participation in this study, within the Study Interest Survey
  12. APP: Identify and obtain signed Research Care (RC) Team Acknowledgements from two members (defined below) of their research care team to assist them in this study. The RC team for this study will consist of an oncologist and clinical research professional (i.e., clinical research coordinator, clinical research associate clinical research nurse, etc.) that the APP collaborated with over the past 6 months or could collaborate with in the future to enroll patients on NCORP and/or NCTN trials
  13. APP: Must have received the required APP practice ID for OPEN enrollment in the Study Selection Email
  14. APP: Must enroll consented APPs in OPEN within 14 days of receiving the Study Selection Email
  15. MENTOR: Must be a practicing APP chosen by the WF-2403 COACH-APP Study MPIs
  16. MENTOR: Must have the following criteria: * Clinical practice experience in a practice that enrolls to NCORP and/or NCTN trials. * Participation in a leadership role within NCTN or NCORP (i.e., serving on a Research Base committee, working group, taskforce or as a site PI) * Willing to complete COACH-APP mentor training. * Willing to complete a 30-minute recorded phone interview about their experience with the COACH-APP intervention
  17. RESEARCH CARE TEAM INTERVIEW: Must be an identified member of the Research Care Team for an APP assigned to the COACH-APP intervention arm. The Research Care Team will be reviewed by the APP in the 12 month survey for any changes
  18. RESEARCH CARE TEAM INTERVIEW: Willing to participate in a recorded phone interview (approximately 30 minutes) to assess their perceptions of the COACH-APP intervention, including feasibility, acceptability, and impact

Treatment Sites in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.